🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
GSK3359609 is an anti-Inducible T cell Co-Stimulator (ICOS) receptor agonis...
Status
Completed
Location
GSK Investigational Site
Start Date
2016-06-23
Trial ID
NCT02723955
TSR-022 (cobolimab, TIM-3 binding antibody) and TSR-042 (dostarlimab, PD-1 ...
Status
Active Not Recruiting
Location
University of Hawaii
Start Date
2019-12-19
Trial ID
NCT03680508
Treatments Being Tested
This first-time-in-human (FTIH) study will evaluate the safety, tolerabilit...
Status
Active Not Recruiting
Location
GSK Investigational Site
Start Date
2020-06-25
Trial ID
NCT04446351
Treatments Being Tested
This research is being done to determine how effective dostarlimab in combi...
Status
Active Not Recruiting
Location
Beth Israel Deaconess Medical Center
Start Date
2024-03-11
Trial ID
NCT06238635
Treatments Being Tested
The purpose of this study is to test the effects of anti-PI-1 inhibitor (TS...
Status
Active Not Recruiting
Location
Georgetown University Medical Center
Start Date
2020-06-12
Trial ID
NCT04139902
Treatments Being Tested
This is a multi-center, parallel group treatment, Phase 2/3 open label stud...
Status
Active Not Recruiting
Location
GSK Investigational Site
Start Date
2020-12-08
Trial ID
NCT04655976
Treatments Being Tested
The goal of this interventional study is to determine the strength of cobol...
Status
Active Not Recruiting
Location
GSK Investigational Site
Start Date
2025-03-06
Trial ID
NCT06521567
Treatments Being Tested